Fundraising FoxOsage University Partners — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas.
BiotechHealthtechMedical DevicesSan Diego, US
Marc Nasoff(Chief Scientific Officer)
BoardJay B. Lichter(Ph.D.)in
Co-investorsVivo CapitalLilly Asia VenturesAvalon BioVenturesOUP (Osage University Partners)
Clarifai developed AI inference technology and compute orchestration software for running and optimizing machine learning models at scale.
AI & Machine LearningCloud ComputingData & InfrastructureNew York, US
Matthew Zeiler(Executive Officer, Director)in
BoardAlbert Wenger(Director)in
Co-investorsBright Pixel CapitalCorazon CapitalGV (Google Ventures)Lux CapitalMenlo VenturesNew Enterprise Associates (NEA)+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.